
|Articles|January 9, 2020
Syneos Health Collaborates with Indegene Omnipresence
Advertisement
Syneos Health, a biopharmaceutical solutions organization, announced a collaboration and minority investment in Indegene Omnipresence and the company’s next generation customer experience platform.
The Omnipresence platform is the result of a strategic alliance with Indegene, a global healthcare tech firm, which brings together Microsoft Power Platform, Dynamics 365, Azure, Office 365 including Teams, LinkedIn and Microsoft AI into a unified customer experience management (CXM) platform verticalized for the healthcare industry. Omnipresence helps life sciences and healthcare organizations drive intelligent customer relationships and experiences.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Datroway for Patients with Metastatic Triple-Negative Breast Cancer Who Are Not PD-1/PD-L1 Inhibitor Candidates
2
What Kinds of Disruption are GLP-1s Expected to Face
3
Eli Lilly and Novo Nordisk Shift Patients From Compounded Drugs to Lower-Cost Weight-Loss Pills: Report
4
The Evolving Relationship Between FDA and Biotech
5




